AstraZeneca Pharma India Ltd. NSE: ASTRAZEN | BSE: 506820

Expensive Performer

Download real time

9186.00 -154.00 (-1.65%)

47.68% Gain from 52W Low

16,926

NSE+BSE Volume

NSE 31 Jul, 2025 3:31 PM (IST)

AstraZeneca Pharma India Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from AstraZeneca Pharma India Ltd. on BSE

Load latest

AstraZeneca Pharma India Ltd.

02 Jun 2025

9186.00

-1.65%

Company Update

AstraZeneca Pharma India Ltd - 506820 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Please find the enclosed intimation in relation to the captioned subject for your reference.

AstraZeneca Pharma India Ltd.

30 May 2025, 09:46PM

9186.00

-1.65%

Company Update

AstraZeneca Pharma India Ltd - 506820 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Please find the enclosed press release of the Company in relation to the financial results.

AstraZeneca Pharma India Ltd.

30 May 2025, 08:33PM

9186.00

-1.65%

Company Update

AstraZeneca Pharma India Ltd - 506820 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Please find the enclosed Annual Secretarial Compliance Report of the Company for reference.

AstraZeneca Pharma India Ltd.

30 May 2025, 08:24PM

9186.00

-1.65%

Company Update

AstraZeneca Pharma India Ltd - 506820 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And …

BSE India

Please find the enclosed intimation as per the captioned subject as per the captioned subject.

AstraZeneca Pharma India Ltd.

30 May 2025, 07:21PM

9186.00

-1.65%

Company Update

AstraZeneca Pharma India Ltd - 506820 - Outcome Of The Board Meeting Held On Friday, May …

BSE India

Please find the enclosed financial results for your reference.

AstraZeneca Pharma India Ltd.

30 May 2025, 05:20PM

9186.00

-1.65%

Board Meeting

AstraZeneca Pharma India Ltd - 506820 - Board Meeting Outcome for Recommendation Of Dividend For The …

BSE India

Recommendation of Dividend for the Financial Year 2024-25

AstraZeneca Pharma India Ltd.

30 May 2025, 09:14AM

9186.00

-1.65%

Company Update

AstraZeneca Pharma India Ltd - 506820 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And …

BSE India

Please find the enclosed intimation of the Company in relation to the captioned subject for your reference.

AstraZeneca Pharma India Ltd.

30 May 2025

9186.00

-1.65%

Annual Report

Annual report for AstraZeneca Pharma India Ltd. for FY-2025

None

AstraZeneca Pharma India Ltd.

29 May 2025

9186.00

-1.65%

Company Update

AstraZeneca Pharma India Ltd - 506820 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And …

BSE India

Please find the enclosed intimation of the Company in relation to the captioned subject for your reference.

AstraZeneca Pharma India Ltd.

21 May 2025

9186.00

-1.65%

Board Meeting

AstraZeneca Pharma India Ltd - 506820 - Board Meeting Intimation for Meeting Of The Board Of …

BSE India

Astrazeneca Pharma India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve 1. The audited financial results of the Company for the quarter and year ended March 31, 2025. 2. To recommend Dividend, if any, on the equity shares of the Company for the financial year 2024-25. We also inform you that the 'Trading Window' remains closed for all Designated Persons, from March 16, 2025 to June 1, 2025 (both days inclusive) in terms of AstraZeneca Pharma India Limited - Code of Conduct for Prevention of Insider Trading framed under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015.

Is AstraZeneca Pharma India Ltd. worth buying?

148 Votes:

Buy 70.95%

Sell 19.59%

Hold 9.46%